WAY-262611
Leverancier: ENZO LIFE SCIENCESTotal Ratings: 0
Avg. Ratings: 0.0 out of 5
DKK1 inhibitor
Wnt pathway agonist acting via inhibition of Dkk1 with no GSK-3β inhibition. TCF-Luciferase EC50=0.63µM. WAY262611 was able to enhance trabecular bone formation rate in the tibia of OVX rats following oral administration.
Formule:
C₂₀H₂₂N₄ |
MDL Nummer:
MFCD20527803 CAS nummer: 1123231-07-1 |
|
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...